High frequency of brain metastases after adjuvant therapy for high-risk melanoma.

Cancer Med · 2017 · PMC5673911 · PMID 28994212

Europe PMC DOI

hedged sentence

0.3800

closest p · 7.6× alpha

0.3800

boldest claim

The sentences

did not reach statistical significanceP = 0.38not close (p > 0.1)

While there appeared to be a trend toward increased risk for CNS progression in patients with an unknown primary this did not reach statistical significance when compared to trunk or extremity primaries ( P = 0.38) or head and neck primaries ( P = 0.33, Fig. 3 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.